Janus Henderson Group PLC Chimerix Inc Transaction History

Janus Henderson Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.76 $65 - $99	-36 Reduced 0.24%	14,811 $29,000
Q2 2022 Aug 15, 2022	BUY	$1.34 - $5.34 $21 - $85	16 Added 0.11%	14,847 $31,000
Q1 2022 May 16, 2022	SELL	$4.58 - $6.8 $2.57 Million - $3.82 Million	-561,991 Reduced 97.43%	14,831 $68,000
Q4 2021 Feb 14, 2022	BUY	$5.23 - $7.18 $361,492 - $496,274	69,119 Added 13.61%	576,822 $3.7 Million
Q3 2021 Nov 16, 2021	BUY	$5.94 - $8.75 $3.02 Million - $4.44 Million	507,703 New	507,703 $3.15 Million

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.